Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CHA Medical Group is a global leader in regenerative medicine, fertility treatments, and biotechnology, headquartered in South Korea. The group operates an extensive network of hospitals, research institutes, and biotech companies, including the publicly traded CHA Biotech and the US-based Matica Biotechnology. Renowned for its pioneering work in stem cell research and in vitro fertilization (IVF), the organization integrates clinical care with advanced R&D to develop cell-based therapies for neurological disorders, oncology, and orthopedics. CHA Medical Group is also a significant player in the global healthcare market, managing major facilities such as the Hollywood Presbyterian Medical Center in Los Angeles and providing specialized CDMO services for cell and gene therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CHA Medical Center.